FAQ

Common side effects include gastrointestinal issues like nausea, vomiting, constipation, and diarrhea. Serious side effects may include electrolyte imbalances, low calcium levels, and signs of intestinal distress such as abdominal pain or bloating.

Kayexalate is contraindicated in patients with hypokalemia (low potassium levels), obstructive bowel disease, and those who are allergic to any of the ingredients in the medication.

The effectiveness and speed at which Kayexalate reduces potassium levels can vary, but it generally takes several hours to days. Continuous monitoring of potassium levels is essential to determine the medication’s effectiveness.

Dovobet is a medication used to treat psoriasis.It combines two active ingredients: calcipotriol and betamethasone.Calcipotriol is a vitamin D analogue that controls the excessive production of skin cells seen in psoriasis,while betamethasone is a corticosteroid that helps reduce itching and inflammation.

Dovobet is typically applied once daily to the affected areas of the skin. It should not be applied to the face, skin folds, or extensively damaged skin.The treatment length can vary depending on the form (gel, ointment, or foam) and the area of application, generally ranging from 4 to 8 weeks.

Common side effects include skin irritation, itching, and redness. More serious side effects might include allergic reactions, effects on calcium metabolism, and possible adrenal suppression if used extensively. Long-term use can lead to skin thinning, increased sensitivity to sunlight, and other systemic effects.

Dovobet should not be used by individuals who have a hypersensitivity to any of its components, have a calcium metabolism disorder, or are suffering from certain types of severe psoriasis like erythrodermic or pustular psoriasis. It is also contraindicated in viral, fungal, or bacterial skin infections.

The safety of Dovobet during pregnancy and breastfeeding is not fully established. It should only be used if the potential benefits justify the potential risk to the fetus or infant. Betamethasone can pass into breast milk, but the effects of calcipotriol during breastfeeding are not known.

Clinical trials have shown Dovobet to be highly effective in treating mild to moderate plaque psoriasis, with significant improvements typically visible within 2 to 4 weeks of starting treatment. However, response rates can vary, and some cases may require extended treatment or additional therapies.

While using Dovobet, it is recommended to avoid excessive exposure to natural or artificial sunlight. Also, avoid using other products containing strong corticosteroids or other treatments that might interact with the medication.